- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07670208
Physical Activity Promoting Active Aging
Physical Activity Promoting Active Aging: An Exploration of Intrinsic Mechanisms and Practical Pathways
This project aims to explore the effects and underlying mechanisms of physical activity in promoting active aging among older adults. The researchers conducted two rounds of progressive randomized controlled intervention trials to verify the effects and mechanisms of a multimodal physical activity intervention on active aging from two dimensions: intervention structure and participation mode.
In Study 1, with a 12-week intervention period, participants were randomly assigned to three groups: a Tai Chi exercise group, a multimodal exercise group, and a daily activity control group. By comparing between-group differences, the study evaluated the effects of different exercise modalities on physical function and subjective active aging.
In Study 2, also with a 12-week intervention period, participants were randomly assigned to two multimodal exercise groups differing in participation mode: an in-person group-based format versus an online individual format. This study examined the moderating effects of different participation modes on both objective and subjective active aging outcomes, while keeping the multimodal physical activity intervention content identical.
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310058
- Department of Sports Science, College of Education, Zhejiang University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Aged 60 years or above;
Capable of engaging in regular physical activities and comprehending basic testing procedures and instructions.
Exclusion Criteria:
- Severe cardiac, pulmonary, or musculoskeletal disorders;
History of neurological or psychiatric conditions that may impair cognitive function (e.g., stroke, Parkinson's disease, Alzheimer's disease, major depressive disorder, etc.);
Missing three or more scheduled intervention sessions during the study period, or requesting discontinuation of participation.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Kein Eingriff: Kontrollgruppe
|
|
|
Experimental: Mehrkomponenten-Übungsgruppe
|
Tai Chi, Baduanjin, strength, balance, and flexibility exercises
|
|
Experimental: Mind-body exercise group
|
Tai Chi, Yoga, and Baduanjin
|
|
Experimental: Online-based multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered via live online streaming and video watching)
|
|
Experimental: In-person multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered in an in-person group format)
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Active aging
Zeitfenster: week0, week6, week12
|
It was measured using the Active Aging Questionnaire.
|
week0, week6, week12
|
|
General self-efficacy
Zeitfenster: week0, week6, week12
|
It was measured using the General Self-Efficacy Scale.
|
week0, week6, week12
|
|
Cognitive function
Zeitfenster: week0, week6, week12
|
Cognitive function was measured using the cognitive subscale of the LEIPAD questionnaire
|
week0, week6, week12
|
|
Cognitive function assessed by the Montreal Cognitive Assessment (MOCA)
Zeitfenster: week0, week6, week12
|
Cognitive function was measured using the Montreal Cognitive Assessment (MOCA).
|
week0, week6, week12
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Height
Zeitfenster: week0, week6, week12
|
week0, week6, week12
|
|
|
Weight
Zeitfenster: week0, week6, week12
|
week0, week6, week12
|
|
|
Body fat percentage
Zeitfenster: week0, week6, week12
|
week0, week6, week12
|
|
|
Vital capacity test
Zeitfenster: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
2-minute high-knee marching in place
Zeitfenster: week0, week6, week12
|
week0, week6, week12
|
|
|
Handgrip strength
Zeitfenster: week0, week6, week12
|
week0, week6, week12
|
|
|
Sit and reach test
Zeitfenster: week0, week6, week12
|
week0, week6, week12
|
|
|
30-second chair stand test
Zeitfenster: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
One-legged stance with eyes closed tesr
Zeitfenster: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
Choice reaction time
Zeitfenster: week0, week6, week12
|
week0, week6, week12
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- ZJU-SSEC/2025/No.6
- 23NDJC001Z (Andere Zuschuss-/Finanzierungsnummer: Key Program of Philosophy and Social Sciences Planning of Zhejiang Province)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .